Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

1.80
Delayed Data
As of Aug 31
 +0.01 / +0.56%
Today’s Change
1.50
Today|||52-Week Range
3.04
-29.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues16.5M22.6M20.6M26.5M
 
 
 
 
 
Cost of Goods Sold6.6M9.3M8.8M10.4M
 
 
 
 
 
Depreciation And Amortization168.2K231.0K493.3K1.2M
 
 
 
 
 
 
Operating ExpensesGross Income9.7M13.1M11.4M14.9M
 
 
 
 
 
General Expenses14.1M24.5M32.1M48.3M
 
 
 
 
 
Research And Development6.7M14.9M15.3M18.6M
 
 
 
 
 
Total Operating Expenses20.9M34.0M41.4M59.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.4M-11.5M-20.8M-33.4M
 
 
 
 
 
Extraordinary Charge0.000.00-65.0K-1.7M
 
 
 
Other Expenses-6.7K-39.1K-68.0K-90.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.4M-11.4M-20.8M-35.1M
 
 
 
 
 
Income Taxes0.000.00-300.0K-25.0K
 
 
 
Net Income-4.4M-11.4M-20.5M-35.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS97.0M110.2M126.9M130.5M
 
 
 
 
 
Shares To Calculate EPS Diluted97.0M110.2M126.9M130.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.10-$0.16-$0.27
 
 
 
 
 
EPS Diluted-$0.05-$0.10-$0.16-$0.27